Radioiodine Therapy of Benign Thyroid Diseases

Authors

  • Derya Cayir Dışkapı Yıldırım Beyazıt Training and Research Hospital, Nuclear Medicine Department
  • Mine Araz Dışkapı Yıldırım Beyazıt Training and Research Hospital, Nuclear Medicine Department

Keywords:

Iodine, Thyroid diseases, Hyperthyroidism, Radioiodine-131, Graves disease

Abstract

Radioiodine-131 (I-131) is used in treatment of benign thyroid diseases with hyperthyroidism; toxic diffuse goiter, toxic nodular goiter and toxic multinodular goiter for long years. Treatment success depends on various factors. The most important factor affecting the success of treatment is the susceptibility to target tissue I-131. This review aims to give information about the physical and biological characteristics of I-131, advantages and disadvantages, indications and contraindications for I-131 therapy, patient preperation and administiration of I-131, dose selection, precautions on possible side effects, evaluation of treatment response and make an overview on the clinical studies about I-131 therapy.

Downloads

Published

2017-03-31

Issue

Vol. 4 No. 1 (2017)

Section

Articles

License

Policy for Journals/Articles with Open Access

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  1. Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work

Policy for Journals / Manuscript with Paid Access

Authors who publish with this journal agree to the following terms:
    1. Publisher retain copyright .

  1. Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .